Hongkai Chang

机构：National Clinical Research Center for Digestive Diseases

发表论文 19 篇 · 总被引 283 次 · h-index 9

代表论文

• PRMT6 promotes tumorigenicity and cisplatin response of lung cancer through triggering 6PGD/ENO1 mediated cell metabolism (2022 · Acta Pharmaceutica Sinica B · 被引 77)
• FTO promotes colorectal cancer progression and chemotherapy resistance via demethylating G6PD/PARP1 (2022 · Clinical and Translational Medicine · 被引 46)
• Decreased SLC27A5 Suppresses Lipid Synthesis and Tyrosine Metabolism to Activate the Cell Cycle in Hepatocellular Carcinoma (2022 · Biomedicines · 被引 37)
• PRMT5 promotes ovarian cancer growth through enhancing Warburg effect by methylating ENO1 (2023 · MedComm · 被引 33)
• Identification of HGD and GSTZ1 as Biomarkers Involved Metabolic Reprogramming in Kidney Renal Clear Cell Carcinoma (2022 · International Journal of Molecular Sciences · 被引 19)
• Tyrosine metabolic reprogramming coordinated with the tricarboxylic acid cycle to drive glioma immune evasion by regulating PD‐L1 expression (2023 · Ibrain · 被引 18)